Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of bi-weekly docetaxel in metastatic breast cancer in patients aged 70 and over
2004-002839-10Phase 2Unknown
- Sponsor
- Unicancer
- Start
- Feb 2005
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of docetaxel in breast cancer, sponsored by Unicancer. Primary endpoints: Change in instrumental activities of daily living (IADL) and Change in basic activities of daily living (ADL). Status: unknown.
02
Drugs
docetaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2004-002839-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002839-10.